Pfizer’s 6.7% Yield Looks Scary — but the Dividend Story Is Stronger Than It Seems

Investors are clearly worried about the safety of Pfizer’s dividend, which is reasonable.

This post was originally published on this site.

About the Author

Staff Writer

Staff Writer

Written by a Staff Writer at this publication, this article reflects the work of our editorial team. Our staff writers cover topics locally and nationally to keep you informed on the top stories of our time.

Leave a Reply

Your email address will not be published. Required fields are marked *